Impacts of Methylenetetrahydrofolate Reductase Genotypes on Hallux Valgus
In Vivo · 2025
DOI: 10.21873/invivo.13815 ↗Kurz gefasst
Fachartikel in der Zeitschrift In Vivo, 2025. Verfasst von Chien-Chung Kuo und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedics, China Medical University Hospital, Taichung, Taiwan, R.O.C. Hauptthemen laut MEDLINE: Methylenetetrahydrofolate Reductase (NADPH2), Genotype, Hallux Valgus, Genetic Predisposition to Disease. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
BACKGROUND/AIM: Hallux valgus (HV) is the most common deformity of the forefoot. Although HV has been strongly associated with a family history, its genetic underpinnings remain unclear. Few studies have examined the relationship between folic acid metabolism, which is critical in normal bone development, and HV. The study aimed to investigate the contribution of methylenetetrahydrofolate reductase (MTHFR) genotypes to the risk of HV. MATERIALS AND METHODS: The MTHFR rs1801133 and rs1801131 genotypes were analyzed in 150 patients with HV and 600 controls without HV, using polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP). RESULTS: The results highlighted a significant difference in the genotypic frequency distributions of MTHFR rs1801133 between the HV cases and non-HV controls (p for trend=0.0024). Specifically, individuals with the homozygous TT genotype at MTHFR rs1801133 exhibited a 2.57-fold increased risk of HV (95% confidence interval=1.49-4.42, p=0.0009). However, those with the CT genotype did not show an elevated risk. Stratified analysis showed no correlation between MTHFR rs1801133 genotypic distributions and different age groups (below or above 51 years) or sex (both p>0.05). Furthermore, no associations were identified between MTHFR rs1801133 and height, weight, or body mass index in relation to HV risk. CONCLUSION: The TT genotype of MTHFR rs1801133 is associated with an increased risk of HV. Subgrouping HV patients based on their MTHFR genotypes and related comorbidities, such as rheumatoid arthritis, may offer a new approach to diagnosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Orthopedics, China Medical University Hospital, Taichung, Taiwan, R.O.C.
- Department of Orthopedics, School of Medicine, China Medical University, Taichung, Taiwan, R.O.C.
- Graduate Institute of Biomedical Sciences, China Medical University, Taichung, Taiwan, R.O.C.
- National Defense Medical Center, Tri-service General Hospital Peng-Hu Branch, Peng-Hu, Taiwan, R.O.C.
- National Defense Medical Center, Tri-service General Hospital, Taipei, Taiwan, R.O.C.
- Terry Fox Cancer Research Laboratory, Department of Medical Research, China Medical University Hospital, Taichung, Taiwan, R.O.C.
Zitieren
APA
Kuo, C. C., Tsai, C. H., Chuang, F. K., Wang, Y. C., Mong, M. C., Yang, Y. C., Shih, H. Y., Hsu, S. W., Chang, W. S., Bau, D. T., & Tsai, C. W. (2025). Impacts of Methylenetetrahydrofolate Reductase Genotypes on Hallux Valgus. In Vivo. https://doi.org/10.21873/invivo.13815
Vancouver
Kuo CC, Tsai CH, Chuang FK, Wang YC, Mong MC, Yang YC, et al. Impacts of Methylenetetrahydrofolate Reductase Genotypes on Hallux Valgus. In Vivo. 2025. doi:10.21873/invivo.13815
BibTeX
@article{Kuo2025,
author = {Kuo, Chien-Chung and Tsai, Chun-Hao and Chuang, Fu-Kai and Wang, Yun-Chi and Mong, Mei-Chin and Yang, Ya-Chen and Shih, Hou-Yu and Hsu, Shih-Wei and Chang, Wen-Shin and Bau, DA-Tian and Tsai, Chia-Wen},
title = {Impacts of Methylenetetrahydrofolate Reductase Genotypes on Hallux Valgus},
journal = {In Vivo},
year = {2025},
doi = {10.21873/invivo.13815}
}
EUVIMED